Fairwinds Cannabis Brand Logo

Fairwinds

Data Snapshot: Jul 04, 2026
$100K+

Jun-2026

Sales

Neutral

Trend

6-Month

111

Product Count

SKUs

$19.93

Avg Price

-21%

YoY Sales Change

-0.7%

YoY Price Change

With a unique combination of ancient herbology and modern technology, Fairwinds Manufacturing is a distinguished pesticide-free cannabis manufacturer operating in Washington State since 2014. The company, known for its customer-praised CBD-enhanced wellness products, capitalizes on the nationwide legalization trend to redefine societal approaches to health. Fairwinds' notable efficiency and consistency result from using an automated cultivation facility specifically designed for replicable results.
Fairwinds Sales

Market Insights Snapshot

Fairwinds Historical Sales by Category

Fairwinds concentrated 53.83% of June 2026 sales in Tincture & Sublingual, where sales were down 19.75% year over year but up 2.17% month over month, while Vapor Pens held 20.07% share with a 3.78% YoY increase and a 3.28% MoM decline. Capsules accounted for 13.85% share with a 24.92% YoY drop and a 4.08% MoM lift, and Topical at 11.02% share declined 29.31% YoY and 3.69% MoM. Peripheral lines contracted sharply as Concentrates fell 67.75% YoY and 27.91% MoM to 0.85% share, and Flower fell 89.84% YoY and 30.79% MoM to 0.33% share, even as Pre-Roll spiked 241.47% MoM from a small base to just 0.06% share after a 57.21% YoY decline. The pattern implies a deliberate tilt toward Tincture & Sublingual and wellness-adjacent formats, absorbing YoY compression in core while trimming breadth in low-share combustion categories to stabilize mix.

With brand sales down 21.01% year over year alongside a 0.66% YoY decrease in average price, the mix shift places Fairwinds’ differentiation on value-accessible Tincture & Sublingual where it ranks 2 in Washington, while using Capsules’ 4.08% MoM uptick to reinforce non-inhalable positioning. Vapor Pens’ 3.78% YoY rise but 3.28% MoM dip suggests opportunistic but non-core participation versus the 2.17% MoM gain in Tincture & Sublingual and the 3.69% MoM Topical decline, indicating priority on formats with repeatable wellness use cases over impulse inhalables. The implication is a defensive share strategy anchored in high-repeat, non-combustion categories to maintain rank in Washington while letting subscale combustion SKUs contract to preserve price architecture and focus marketing on the leading pillar.

Jun-2026 Rank
Capsules
Tincture & Sublingual
Topical
Vapor Pens
2
2
4
78
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Tincture & Sublingual
53.8%
$20.54
-19.8%
+2.2%
Vapor Pens
20.1%
$21.31
+3.8%
-3.3%
Capsules
13.8%
$16.62
-24.9%
+4.1%
Topical
11.0%
$20.05
-29.3%
-3.7%
Concentrates
0.8%
$24.08
-67.7%
-27.9%
Flower
0.3%
$11.89
-89.8%
-30.8%
Pre-Roll
0.1%
$6.39
-57.2%
+241.5%
Fairwinds

Competitive Landscape

Fairwinds sits at rank #2 in Washington Tincture & Sublingual for June 2026, down 1 position from rank #1 year over year, and unchanged versus March 2026 at #2, while its peak rank was #1 in July 2025. In contrast, Green Revolution holds #1 after rising from #2 year over year while posting a 9.0% YoY sales decline, and HiKu remains at #4 with a 60.5% YoY sales increase, signaling faster momentum below the top two. The pattern—Fairwinds slipping 1 rank as the leader advanced 1 rank despite negative YoY sales and mid-pack challengers posted +60.5% and +43.6%—implies the #2 position is stable in the near term but faces upward pressure from faster-growing competitors and limited headroom against a leader that is defending share without growth.

Fairwinds market ranking for WA Tincture & Sublingual

Fairwinds

Notable Products

Indica Lifestyle Tincture (100mg) posted the steepest decline at -28.4% MoM and slid to rank 8, while CBD/CBN/THC 5:5:1 Deep Sleep Tincture (250mg CBD, 250mg CBN, 50mg THC, 0.45 fl oz) fell -13.9% MoM to rank 3, indicating sleep- and relaxation-led SKUs are losing momentum as June 2026 demand tilts away from sedating formats. In contrast, CBD/THC 5:1 Companion Savory Bacon 64x Tincture (200mg CBD, 40mg THC, 8ml, 0.54 fl oz) rose 30.0% MoM to rank 1 and generated $33,503, while its 32x sibling climbed 18.1% MoM to rank 2, creating a 1–2 finish that concentrates velocity in the Companion flavor line. With seven of the top ten in Tincture & Sublingual, the portfolio is concentrated in one format even as Capsules at ranks 4 and 9 grew modestly between +1.3% and +4.3%, implying room to diversify dose-controlled SKUs without diluting the core tincture franchise.

Product
Category
Feb-2026
Mar-2026
Apr-2026
May-2026
Jun-2026
MoM %
CBD/THC 5:1 Companion Savory Bacon 64x Tincture (200mg CBD, 40mg THC, 8ml, 0.54 fl oz)
Tincture & Sublingual
1
1
1
1
1
+30.0%
CBD/THC 5:1 Companion Savory Bacon 32x Tincture (100mg CBD, 20mg THC, 0.27 fl oz, 8ml)
Tincture & Sublingual
3
3
3
3
2
+18.1%
CBD/CBN/THC 5:5:1 Deep Sleep Tincture (250mg CBD, 250mg CBN, 50mg THC, 0.45 fl oz)
Tincture & Sublingual
2
2
2
2
3
-13.9%
CBD/CBG/THC FECO High Potency 20-Pack (1000mg CBD, 1000mg CBG, 40mg THC)
Capsules
5
6
6
5
4
+1.3%
CBD/THC 1:1 Ratio Tincture (100mg CBD, 100mg THC, 0.26oz)
Tincture & Sublingual
6
5
5
6
5
-5.2%
CBD Sativa Lifestyle Tincture (100mg, 2oz)
Tincture & Sublingual
9
>10
8
9
6
+11.9%
CBD/THC 5:1 Companion Roasted Chicken 32x Tincture (100mg CBD, 20mg THC, 0.27 fl oz)
Tincture & Sublingual
>10
10
>10
>10
7
Indica Lifestyle Tincture (100mg)
Tincture & Sublingual
8
7
4
4
8
-28.4%
CBD/THC/CBN 10:2:10 Deeper Sleep Plus CBN Capsule 15-Pack (150mg CBD, 30mg THC, 150mg CBN)
Capsules
7
8
>10
10
9
+4.3%
CBD/THC 10:1 Ratio Live Resin Cartridge (1g)
Vapor Pens
10
>10
>10
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market